Skip to main content
Clinical Trials/NCT06824038
NCT06824038CompletedNot Applicable

Impact of Nutrition Counseling on the Nutritional Status of Patients with Ulcerative Colitis: a Randomized Controlled Clinical Trial

Rahma Mohammed Medhat Ali1 site in 1 country160 target enrollmentStarted: September 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
160
Locations
1
Primary Endpoint
nutritional status

Study Overview

Brief Summary

randomized clinical trial aimed to find whether, In ulcerative colitis patients, nutrition counseling is associated with improved nutritional status.

objectives:

  1. Asses the nutritional status and quality of life among a sample of UC patients attending the NHTMRI outpatient clinic.
  2. Provide nutritional counseling for the randomly allocated intervention group
  3. Evaluate the effect of the nutritional counseling on nutritional status, quality of life and disease progression.
  • Inclusion criteria: patients with moderate Ulcerative Colitis, in active phase. Adults aged 18-60, of both sexes

Patients in the intervention group will receive a counseling session then instructs on the subsequent follow up dates. Each patient of the intervention group is scheduled to receive weekly session, according to settled appointments; while the control arm will receive the regular service at the clinic.

Detailed Description

Administrative and Preparatory Phase:

After obtaining approval from the corresponding parties, a booklet in Arabic language with educational material and instruction will be prepared. Common foods for and against bowel discomfort will be emphasized. Dietary records will be included to check the adherence of the patients to the instructions.

II- Pre-intervention phase (The initial assessment):

The investigator will review the medical record of each patient to confirm the diagnosis and severity; then eligible patients in both counseling arm and the control arm will be interviewed by the investigator using a structured questionnaire to gather the following data for the initial assessment Personal and socio-demographic data: Comprised enquiry about each patient's age, sex, marital status, occupation, education, residency and telephone/mobile number.

b. Assessment of the quality of life using the short inflammatory bowel disease questionnaire (SIBDQ). It is a set of generic, coherent, and easily administered quality of life measures. Scores are from 0 to 10. A higher score indicates better health.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with moderate Ulcerative Colitis, in active phase.
  • •Adults aged 18-60, of both sexes

Exclusion Criteria

  • •Patients with acute fulminant colitis.
  • •Patient with weight loss > 5% in the last month, and >10% weight loss in the last 6 months.

Arms & Interventions

intervention group

Experimental

Patients with moderate Ulcerative Colitis, in active phase, Ages: Adults aged 18-60, of both sexes. Intervention: will receive nutritional counseling sessions ,nd weekly follow-up through clinic vists and mobile phones and messaging

Intervention: nutritional counseling (Behavioral)

control group

No Intervention

Patients with moderate Ulcerative Colitis, in active phase. Adults aged 18-60, of both sexes.

will receive regular care of the clinic.

Outcomes

Primary Outcomes

nutritional status

Time Frame: three months

weight in kilograms ,

dietary habits

Time Frame: three months

Dietary habits questionnaire to asses the cooking methods and daily habits.

quality of life score

Time Frame: three months

asses the QoL through the Short Inflammatory Bowel Disease Questionnaire SIBDQ score. It consists of 10 questions. Each question is scored by a 7-point Likert scale, ranging from 1 (a severe problem) to 7 (not a problem at all), giving an absolute SIBDQ score ranging from 10 (poor health related quality of life "HRQoL") to 70 (optimal HRQoL).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Rahma Mohammed Medhat Ali
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Rahma Mohammed Medhat Ali

assistant lecturer

Cairo University

Study Sites (1)

Loading locations...

Similar Trials